To assess the therapeutic potential of CTHRC1 in the early phase of acute MI, we induced MI by coronary artery ligation followed by a continuous intraperitoneal injection of rCTHRC1 protein for 7 days (1 μg/d) (Figure 8I). This evidence concerns the gene CTHRC1 and myocardial infarction.